NCT01100411

Brief Summary

The purpose of this study is to evaluate changes in contact lens geometry after lens wear

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 7, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 9, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
Last Updated

July 18, 2012

Status Verified

November 1, 2011

Enrollment Period

4 months

First QC Date

April 7, 2010

Last Update Submit

July 17, 2012

Conditions

Keywords

Contact lenses, myopia, lens geometry

Outcome Measures

Primary Outcomes (1)

  • Lens Geometry

    1 week

Secondary Outcomes (2)

  • Corneal Shape

    1 week

  • Conjunctival Staining

    1 week

Study Arms (6)

Air Optix Aqua

ACTIVE COMPARATOR

Contact lens material: Lotrafilcon A

Device: Air Optix Aqua

Biofinity

ACTIVE COMPARATOR

Contact lens material: Comfilcon A

Device: Biofinity

Proclear

ACTIVE COMPARATOR

Contact lens material: Omafilcon A

Device: Proclear

Acuvue Oasys

ACTIVE COMPARATOR

Contact lens material: Senofilcon A

Device: Acuvue Oasys

Acuvue 2

ACTIVE COMPARATOR

Contact lens material: Etafilcon A

Device: Acuvue 2

Purevision

ACTIVE COMPARATOR

Contact lens material: Balafilcon A

Device: Purevision

Interventions

Contact lens material: Lotrafilcon A

Also known as: Air Optix
Air Optix Aqua
BiofinityDEVICE

Contact lens material: Comfilcon A

Also known as: CV Biofininty
Biofinity
ProclearDEVICE

Contact lens material: Omafilcon A

Also known as: Proclear Compatibles
Proclear

Contact lens material: Senofilcon A

Also known as: Oasys
Acuvue Oasys
Acuvue 2DEVICE

Contact lens material: Etafilcon A

Also known as: AV 2
Acuvue 2

Contact lens material: Balafilcon A

Also known as: PV
Purevision

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent;
  • Be at least 18 years old;
  • Willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
  • Have ocular health findings considered to be "normal" and which would not prevent the participant from safely wearing contact lenses;
  • Has vision correctable to at least 6/12 (20/40) or better at distance in each eye with contact lenses;
  • Be experienced at wearing contact lenses.

You may not qualify if:

  • Any pre-existing ocular irritation, injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses;
  • Any systemic disease that adversely affects ocular health
  • An active corneal infection or any active ocular disease that would affect wearing of contact lenses;
  • Use of any topical ocular medication during trial with the exception of saline drops ;
  • Use of or a need for any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant's ocular health/physiology or contact lens performance
  • Eye surgery within 12 weeks immediately prior to enrolment for this trial;
  • Previous corneal refractive surgery;
  • Contraindications to contact lens wear;
  • Participated or currently enrolled in another clinical trial that may have affected vision or ocular physiology within the previous 2 weeks;
  • Be pregnant (formal testing of pregnancy is not required. A participant's verbal report is sufficient);
  • Worn soft contact lenses 2 calendar days or rigid gas permeable/ orthokeratology lenses 7 calendar days prior.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for Eye Research

Sydney, New South Wales, 2052, Australia

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Alcon Call Center

    Alcon Research

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2010

First Posted

April 9, 2010

Study Start

March 1, 2010

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

July 18, 2012

Record last verified: 2011-11

Locations